Nadolol
- Product NDC
- 10135-687
- 11-digit product format
- 101350687
- Labeler code
- 10135
- Product ID
- 10135-687_ec9ce5e5-ab42-2364-e053-2a95a90afdde
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nadolol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Marlex Pharmaceuticals Inc
- Application
- ANDA210955
- Marketing category
- ANDA
- Marketing start
- 2020-03-01
- Marketing end
- 0000-00-00
- Substance
- NADOLOL
- Active strength
- 40 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10135-687-01 | Nadolol | 100 in 1 BOTTLE | TABLET | 100 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10135-687 | NADOLOL TABLET [MARLEX PHARMACEUTICALS INC] | 5 | Legacy NDC, 1 package rows | 20231205_3332d348-4ef9-47bb-8354-3101244b299b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 10135-687-01 | 10135068701 | 100 TABLET in 1 BOTTLE (10135-687-01) | 100 tablet | 2020-03-01 | 0000-00-00 | No | No | Current |